NEW YORK (GenomeWeb) – Biocartis reported today a 57 percent increase in revenues for the full year 2015.

The Belgian molecular diagnostics firm said that total revenues climbed to €13.3 million ($15.1 million) from €8.5 million in 2014. Collaboration revenue more than tripled to €9.7 million from €3.2 million a year ago. Product sales revenue dropped 32 percent to €3.6 million from €5.3 million in 2014.

In a statement accompanying the release of results, Biocartis said it added collaborations with Microbiome, Fast-track diagnostics, A*Star, Merck KGaA, and Amgen in 2015.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.